1.
Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge.
Kidney international Supplement. 2005(98):S11-7.
2.
Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on
developing nations: a 21st century challenge in global health. Nephron Clinical practice.
2011;118(3):c269-77.
3.
Chen J. Epidemiology of hypertension and chronic kidney disease in China. Current
opinion in nephrology and hypertension. 2010;19(3):278-82.
4.
Chung H-F, Al Mamun A, Huang M-C, Long KZ, Huang Y-F, Shin S-J, et al. Obesity, weight
change, and chronic kidney disease in patients with type 2 diabetes mellitus: A longitudinal
study in Taiwan. Journal of diabetes. 2017;9(11):983-93.
5.
Liu M, Liu SW, Wang LJ, Bai YM, Zeng XY, Guo HB, et al. Burden of diabetes, hyperglycaemia
in China from to 2016: Findings from the 1990 to 2016, global burden of disease study.
Diabetes & metabolism. 2018.
6.
Zhang L, Zuo L, Wang F, Wang M, Wang S, Liu L, et al. Metabolic syndrome and chronic
kidney disease in a Chinese population aged 40 years and older. Mayo Clinic proceedings.
2007;82(7):822-7.
7.
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men
and women in China. The New England journal of medicine. 2010;362(12):1090-101.
8.
Ho Y-W, Chau K-F, Choy B-Y, Fung K-S, Cheng Y-L, Kwan T-H, et al. Hong Kong Renal
Registry Report 2010. Hong Kong Journal of Nephrology. 2010;12(2):81-98.
9.
Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney
disease in Taiwan. Nephrology (Carlton, Vic). 2010;15 Suppl 2:3-9.
10.
Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control
of hypertension in China: results from a national survey. American journal of hypertension.
2014;27(11):1355-61.
11.
Shan Y, Zhang Q, Liu Z, Hu X, Liu D. Prevalence and risk factors associated with chronic
kidney disease in adults over 40 years: a population study from Central China. Nephrology
(Carlton, Vic). 2010;15(3):354-61.
12.
Liu X, Li Y, Guo Y, Li L, Yang K, Liu R, et al. The burden, management rates and influencing
factors of high blood pressure in a Chinese rural population: the Rural Diabetes,
Obesity and Lifestyle (RuralDiab) study. Journal of human hypertension. 2018;32(3):236-46.
13.
Liu X, Li Y, Li L, Zhang L, Ren Y, Zhou H, et al. Prevalence, awareness, treatment,
control of type 2 diabetes mellitus and risk factors in Chinese rural population:
the RuralDiab study. Scientific reports. 2016;6:31426.
14.
Jha V. Herbal medicines and chronic kidney disease. Nephrology (Carlton, Vic). 2010;15
Suppl 2:10-7.
15.
Yang B, Xie Y, Guo M, Rosner MH, Yang H, Ronco C. Nephrotoxicity and Chinese Herbal
Medicine. Clinical journal of the American Society of Nephrology : CJASN. 2018;13(10):1605-11.
16.
Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency
prevalence guides population screening: Results from the NHANES III. Kidney international.
2002;61(6):2165-75.
17.
Ramirez SP, McClellan W, Port FK, Hsu SI. Risk factors for proteinuria in a large,
multiracial, southeast Asian population. Journal of the American Society of Nephrology
: JASN. 2002;13(7):1907-17.
18.
Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, et al. Community-based study on CKD
subjects and the associated risk factors. Nephrology, dialysis, transplantation :
official publication of the European Dialysis and Transplant Association - European
Renal Association. 2009;24(7):2117-23.
19.
Liu LS. [2010 Chinese guidelines for the management of hypertension]. Zhonghua xin
xue guan bing za zhi. 2011;39(7):579-615.
20.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new
equation to estimate glomerular filtration rate. Annals of internal medicine. 2009;150(9):604-12.
21.
Chapter 1: Definition and classification of CKD. Kidney International Supplements.
2013;3(1):19-62.
22.
[Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua
xin xue guan bing za zhi. 2007;35(5):390-419.
23.
Wang S-S, Lay S, Yu H-N, Shen S-R. Dietary Guidelines for Chinese Residents (2016):
comments and comparisons. Journal of Zhejiang University Science B. 2016;17(9):649-56.
24.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International
physical activity questionnaire: 12-country reliability and validity. Medicine and
science in sports and exercise. 2003;35(8):1381-95.
25.
Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y, et al. Prevalence and factors associated
with CKD: a population study from Beijing. American journal of kidney diseases : the
official journal of the National Kidney Foundation. 2008;51(3):373-84.
26.
Chen W, Chen W, Wang H, Dong X, Liu Q, Mao H, et al. Prevalence and risk factors associated
with chronic kidney disease in an adult population from southern China. Nephrology,
dialysis, transplantation : official publication of the European Dialysis and Transplant
Association - European Renal Association. 2009;24(4):1205-12.
27.
Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney
disease in China: a cross-sectional survey. The Lancet. 2012;379(9818):815-22.
28.
Liu ZH. Nephrology in china. Nature reviews Nephrology. 2013;9(9):523-8.
29.
Chen J, Wildman RP, Gu D, Kusek JW, Spruill M, Reynolds K, et al. Prevalence of decreased
kidney function in Chinese adults aged 35 to 74 years. Kidney international. 2005;68(6):2837-45.
30.
Zhang L, Zuo L, Xu G, Wang F, Wang M, Wang S, et al. Community-based screening for
chronic kidney disease among populations older than 40 years in Beijing. Nephrology,
dialysis, transplantation : official publication of the European Dialysis and Transplant
Association - European Renal Association. 2007;22(4):1093-9.
31.
Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management
of chronic kidney disease in China. American journal of nephrology. 2008;28(1):1-7.
32.
Chen W, Liu Q, Wang H, Chen W, Johnson RJ, Dong X, et al. Prevalence and risk factors
of chronic kidney disease: a population study in the Tibetan population. Nephrology,
dialysis, transplantation : official publication of the European Dialysis and Transplant
Association - European Renal Association. 2011;26(5):1592-9.
33.
Cao Y, Li W, Yang G, Liu Y, Li X. Diabetes and hypertension have become leading causes
of CKD in Chinese elderly patients: a comparison between 1990-1991 and 2009-2010.
International urology and nephrology. 2012;44(4):1269-76.
34.
Qin X, Wang Y, Li Y, Xie D, Tang G, Wang B, et al. Risk factors for renal function
decline in adults with normal kidney function: a 7-year cohort study. Journal of epidemiology
and community health. 2015;69(8):782-8.
35.
Levey AS, Bilous R, Shlipak MG. CKD and Diabetes: What Can We Learn From Their Similarities
and Differences? American journal of kidney diseases : the official journal of the
National Kidney Foundation. 2016;67(3):360-3.
36.
Hongding X, Wei W, Canqun L. A epidemiological study on DM 1995-1996 in China. Chin
J Diab. 1998;6:131-3.
37.
Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional,
and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic
analysis of health examination surveys and epidemiological studies with 370 country-years
and 2· 7 million participants. The Lancet. 2011;378(9785):31-40.
38.
Tao S, Wu X, Duan X, Fang W, Hao J, Fan D, et al. Hypertension prevalence and status
of awareness, treatment and control in China. Chinese medical journal. 1995;108(7):483-9.
39.
Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment,
and control of hypertension in china. Hypertension (Dallas, Tex : 1979). 2002;40(6):920-7.
40.
Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of Hypertension in
China: Results From the China Hypertension Survey, 2012-2015. Circulation. 2018;137(22):2344-56.
41.
Hager MR, Narla AD, Tannock LR. Dyslipidemia in patients with chronic kidney disease.
Reviews in endocrine & metabolic disorders. 2017;18(1):29-40.
42.
Ji B, Zhang S, Gong L, Wang Z, Ren W, Li Q, et al. The risk factors of mild decline
in estimated glomerular filtration rate in a community-based population. Clin Biochem.
2013;46(9):750-4.
43.
Tsai CW, Huang HC, Chiang HY, Chung CW, Chang SN, Chu PL, et al. Longitudinal lipid
trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.
J Lipid Res. 2019;60(3):648-60.
44.
Isaka Y, Takabatake Y, Takahashi A, Saitoh T, Yoshimori T. Hyperuricemia-induced inflammasome
and kidney diseases. Nephrology, dialysis, transplantation : official publication
of the European Dialysis and Transplant Association - European Renal Association.
2016;31(6):890-6.
45.
Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS. Uric acid and
incident kidney disease in the community. Journal of the American Society of Nephrology
: JASN. 2008;19(6):1204-11.
46.
Zhang L, Wang F, Wang X, Liu L, Wang H. The association between plasma uric acid and
renal function decline in a Chinese population-based cohort. Nephrology, dialysis,
transplantation : official publication of the European Dialysis and Transplant Association
- European Renal Association. 2012;27(5):1836-9.
47.
Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor
for new-onset chronic kidney disease?: A systematic review and meta-analysis based
on observational cohort studies. BMC nephrology. 2014;15:122.